{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:53:08Z","timestamp":1761893588297},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":286,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:p>Histological transformation from a follicular non\u2010Hodgkin's lymphoma (NHL) to a higher grade lymphoma carries a poor prognosis despite treatment with aggressive anthracycline\u2010based chemotherapy. We retrospectively analysed 35 patients with histologically transformed NHL who underwent high\u2010dose therapy and autotransplantation at our centre. Patients up to 65\u2003years old were eligible for autotransplant at the time of transformation or with subsequent relapses, provided that chemosensitivity to a salvage regimen could be demonstrated. All patients received high\u2010dose therapy [etoposide 60\u2003mg\/kg, melphalan 160\u2003mg\/m<jats:sup>2<\/jats:sup> and fractionated total body irradiation (TBI) 12\u2003Gy] followed by unpurged autologous bone marrow or blood stem cell rescue. Most patients (69%) had advanced stage disease (stages 3\u20134) at transformation and bone marrow involvement was common (49%). Twenty\u2010six (74%) patients were in partial remission (PR) and nine (26%) in complete remission (CR) at the time of transplant. Median duration from transformation to transplant was 10\u00b79\u2003months (range, 5\u00b72\u2003months\u22124\u00b76\u2003years). At a median follow up of 52\u2003months after autotransplant, 19 (54%) patients had died. Causes of death were progressive lymphoma in nine patients (26%), treatment\u2010related mortality (TRM) in seven (20%) and myelodysplasia in three (8%). Only five patients in our cohort were &gt;\u200a60\u2003years old, but all died as a result of treatment\u2010related causes (mostly pulmonary infections). Five\u2010year overall survival and progression\u2010free survival from time of transplant were 37% and 36% respectively. Using multivariate analysis of factors including gender, age, stage, extranodal disease, disease bulk, B symptoms, number of prior therapies, relapse status and CR\/PR status at transplant, only advanced age significantly predicted for survival from autotransplant (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7002). Our survival data are comparable to previous reports of autotransplantation for transformed NHL and suggest a benefit over standard chemotherapy alone in selected patients. However, our high TRM cautions the use of aggressive therapy, including TBI, in patients over 60\u2003years old.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02705.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:33:10Z","timestamp":1047364390000},"page":"202-208","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Autotransplants for histologically transformed follicular non\u2010Hodgkin's lymphoma"],"prefix":"10.1111","volume":"113","author":[{"given":"Christine I.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Crump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Keith","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armand","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.1.11"},{"key":"e_1_2_5_3_1","first-page":"413","article-title":"Diffuse histiocytic lymphoma after histologic conversion: a poor prognostic variant","volume":"65","author":"Armitage J.O.","year":"1981","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.8.3257.3257"},{"key":"e_1_2_5_5_1","first-page":"3562","article-title":"The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial","volume":"92","author":"Blay J.\u2010Y.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_5_6_1","first-page":"279","article-title":"Prognostic factors in patients who received autologous bone marrow transplantation for non\u2010Hodgkin's lymphoma. Report of 104 patients from the Spanish cooperative Group GEL\/TAMO","volume":"14","author":"Conde E.","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1989.tb01205.x"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008349427337"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.5.784"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.11.2524.2524"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.1999.v5.pm10465106"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.10.1470"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830801)52:3<393::AID-CNCR2820520302>3.0.CO;2-M"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008294725992"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198412063112303"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V59.2.258.258"},{"key":"e_1_2_5_18_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation for incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"Journal of the American Statistical Association"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-2728-9"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.588"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198212000-00014"},{"key":"e_1_2_5_24_1","first-page":"929","article-title":"Nodular poorly differentiated lymphocytic lymphoma: changes in histology and survival","volume":"65","author":"Ostrow S.S.","year":"1981","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840301)53:5<1109::AID-CNCR2820530516>3.0.CO;2-O"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332305"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.437976.x"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700772"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197908)44:2<529::AID-CNCR2820440222>3.0.CO;2-Y"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.7.2579.2579"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.1.117.117"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.10.1846"},{"key":"e_1_2_5_34_1","first-page":"685a","article-title":"Chemosensitive transformed follicular non\u2010hodgkin's lymphoma (NHL) is a firm indication for high\u2010dose therapy and autologous stem cell transplantation","volume":"88","author":"Williams C.D.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.7.1726"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02705.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02705.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02705.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T09:53:39Z","timestamp":1697536419000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02705.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02705.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02705.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]},"assertion":[{"value":"2002-01-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}